ValuEngine Upgrades Omega Healthcare Investors (OHI) to Buy

ValuEngine upgraded shares of Omega Healthcare Investors (NYSE:OHI) from a hold rating to a buy rating in a research note published on Tuesday morning.

Several other equities research analysts also recently weighed in on OHI. Zacks Investment Research upgraded Omega Healthcare Investors from a sell rating to a hold rating in a report on Wednesday, October 31st. TheStreet upgraded Omega Healthcare Investors from a c rating to a b- rating in a report on Thursday, November 8th. Bank of America restated a hold rating on shares of Omega Healthcare Investors in a report on Monday, November 19th. Cantor Fitzgerald restated a buy rating and set a $34.00 price target on shares of Omega Healthcare Investors in a report on Monday, August 6th. Finally, MED upped their price target on Omega Healthcare Investors to $34.00 and gave the stock a neutral rating in a report on Monday, November 5th. Eight analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Omega Healthcare Investors currently has an average rating of Hold and a consensus target price of $32.50.

OHI stock opened at $36.33 on Tuesday. The company has a current ratio of 4.17, a quick ratio of 4.17 and a debt-to-equity ratio of 1.21. The firm has a market capitalization of $7.28 billion, a P/E ratio of 11.01, a PEG ratio of 7.03 and a beta of 0.13. Omega Healthcare Investors has a 12-month low of $24.90 and a 12-month high of $36.54.

Omega Healthcare Investors (NYSE:OHI) last issued its quarterly earnings results on Monday, November 5th. The real estate investment trust reported $0.28 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.74 by ($0.46). Omega Healthcare Investors had a return on equity of 7.32% and a net margin of 31.91%. The company had revenue of $192.30 million for the quarter, compared to analysts’ expectations of $194.40 million. During the same quarter last year, the company earned $0.79 EPS. Omega Healthcare Investors’s revenue for the quarter was down .9% compared to the same quarter last year. On average, research analysts expect that Omega Healthcare Investors will post 2.97 EPS for the current year.

The business also recently declared a quarterly dividend, which was paid on Thursday, November 15th. Shareholders of record on Wednesday, October 31st were issued a dividend of $0.66 per share. The ex-dividend date of this dividend was Tuesday, October 30th. This represents a $2.64 annualized dividend and a yield of 7.27%. Omega Healthcare Investors’s dividend payout ratio (DPR) is 80.00%.

In other Omega Healthcare Investors news, insider Michael Ritz sold 2,000 shares of the company’s stock in a transaction dated Monday, November 19th. The stock was sold at an average price of $35.50, for a total transaction of $71,000.00. Following the sale, the insider now owns 8,076 shares in the company, valued at approximately $286,698. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 1.65% of the stock is owned by corporate insiders.

Several large investors have recently added to or reduced their stakes in the company. BlackRock Inc. boosted its position in shares of Omega Healthcare Investors by 2.7% during the 3rd quarter. BlackRock Inc. now owns 22,472,026 shares of the real estate investment trust’s stock worth $736,410,000 after acquiring an additional 600,867 shares in the last quarter. Bank of New York Mellon Corp boosted its position in shares of Omega Healthcare Investors by 14.9% during the 2nd quarter. Bank of New York Mellon Corp now owns 5,689,457 shares of the real estate investment trust’s stock worth $176,373,000 after acquiring an additional 736,393 shares in the last quarter. Daiwa Securities Group Inc. boosted its position in shares of Omega Healthcare Investors by 43.9% during the 2nd quarter. Daiwa Securities Group Inc. now owns 5,032,761 shares of the real estate investment trust’s stock worth $156,015,000 after acquiring an additional 1,536,523 shares in the last quarter. LSV Asset Management boosted its position in shares of Omega Healthcare Investors by 0.7% during the 2nd quarter. LSV Asset Management now owns 4,899,233 shares of the real estate investment trust’s stock worth $151,876,000 after acquiring an additional 32,500 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its position in shares of Omega Healthcare Investors by 0.4% during the 3rd quarter. Dimensional Fund Advisors LP now owns 3,115,660 shares of the real estate investment trust’s stock worth $102,097,000 after acquiring an additional 11,565 shares in the last quarter. 73.10% of the stock is owned by institutional investors and hedge funds.

Omega Healthcare Investors Company Profile

Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.

Further Reading: Can systematic risk be avoided?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply